<?xml version='1.0' encoding='UTF-8'?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:webfeeds="http://webfeeds.org/rss/1.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title>eLife: latest articles by subject</title>
    <link>https://elifesciences.org</link>
    <description>Articles published by eLife, filtered by given subjects</description>
    <atom:link href="https://observer.elifesciences.org/report/latest-articles-by-subject" rel="self"/>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>observer (using python-feedgen)</generator>
    <language>en</language>
    <lastBuildDate>Fri, 09 Oct 2026 16:48:25 +0000</lastBuildDate>
    <webfeeds:analytics id="G-TZ0BM7CV5E" engine="GoogleAnalytics"/>
    <item>
      <title>Heterogeneity and ontogeny of mouse thymic macrophages reveal a requirement for &lt;i&gt;Csf1r&lt;/i&gt;-expressing myeloid cells during early T cell development</title>
      <link>https://elifesciences.org/articles/109219</link>
      <description>Thymic macrophages (TMs) maintain tissue homeostasis by clearing the large numbers of apoptotic cells generated during T cell development, but how TM heterogeneity relates to their developmental origin and role in thymocyte maturation remains incompletely understood. Using complementary flow-cytometric, single-cell transcriptomic, and genetic approaches, we resolved two major TM populations corresponding to TIMD4&lt;sup&gt;+&lt;/sup&gt; cortical and CX3CR1&lt;sup&gt;+&lt;/sup&gt; medullary/cortico-medullary macrophages. TIMD4&lt;sup&gt;+&lt;/sup&gt; VCAM1&lt;sup&gt;+&lt;/sup&gt; TMs displayed a prominent efferocytosis and apoptotic-cell-clearance program, whereas TIMD4&lt;sup&gt;-&lt;/sup&gt; VCAM1&lt;sup&gt;+&lt;/sup&gt; TMs were enriched for antigen-presentation and interferon-response pathways. Fate mapping revealed unequal progenitor contributions to these populations, and CCR2 deficiency selectively reduced TIMD4&lt;sup&gt;-&lt;/sup&gt; VCAM1&lt;sup&gt;+&lt;/sup&gt; TMs, and thymic monocytes, supporting ongoing input from circulating precursors. Exploratory pseudotime analysis further identified a transcriptional continuum from &lt;i&gt;Ly6c2&lt;/i&gt;&lt;sup&gt;+&lt;/sup&gt;&lt;i&gt;Ccr2&lt;/i&gt;&lt;sup&gt;+&lt;/sup&gt; monocytes toward macrophage states. Using MaFIA fetal thymic organ cultures, AP20187-mediated depletion of &lt;i&gt;Csf1r-&lt;/i&gt;expressing myeloid cells reduced CD4&lt;sup&gt;+&lt;/sup&gt;CD8&lt;sup&gt;+&lt;/sup&gt; thymocyte differentiation and produced a coordinated accumulation of DN3 cells, loss of DN4 cells, and reduction in CD27 expression. These convergent changes identify the DN3-to-DN4 transition as a developmental stage that requires an intact &lt;i&gt;Csf1r&lt;/i&gt;-expressing myeloid compartment and establish a functional connection between the thymic myeloid niche and early αβ T cell development. Together, our study refines the phenotypic and developmental organization of mouse TMs and reveals a previously underappreciated requirement for myeloid-cell support during progression through the β-selection checkpoint.</description>
      <author>jczp@sri.utoronto.ca (Anthony Wong)</author>
      <author>jczp@sri.utoronto.ca (Helen Wang)</author>
      <author>jczp@sri.utoronto.ca (Juan Carlos Zúñiga-Pflücker)</author>
      <author>jczp@sri.utoronto.ca (Slava Epelman)</author>
      <author>jczp@sri.utoronto.ca (Vinothkumar Rajan)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.109219</guid>
      <category>Immunology and Inflammation</category>
      <pubDate>Wed, 07 Oct 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-10-07T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Human CD1c-autoreactive T-cells recognise &lt;i&gt;Mycobacterium tuberculosis&lt;/i&gt;-infected antigen-presenting cells and display cytotoxic effector programmes</title>
      <link>https://elifesciences.org/articles/110341</link>
      <description>Tuberculosis (TB), caused by &lt;i&gt;Mycobacterium tuberculosis&lt;/i&gt; (Mtb), remains the leading cause of death from infection globally yet the contribution of non-classical T-cell pathways to human immunity remains poorly defined. CD1c-autoreactive T-cells, which recognise self-lipids presented by the antigen-presenting molecule CD1c, are frequent in human blood but their role during infection remains unclear. Here, we investigate how CD1c-expressing antigen-presenting cells (APCs) and Mtb infection shape CD1c-autoreactive T-cell responses using engineered human APC systems, complemented by single-cell transcriptomic profiling to define the ex vivo phenotypic landscape of these T-cells. CD1c is present within human TB granulomas, whereas Mtb down-modulates CD1c expression on infected APCs, consistent with an immune evasion strategy. CD1c-autoreactive T-cells respond more strongly to Mtb-infected CD1c&lt;sup&gt;+&lt;/sup&gt; APCs than to uninfected cells, exhibiting enhanced activation, cytotoxicity, and diverse cytokine secretion via CD1c-dependent recognition. Under in vitro conditions, these T-cells reduce relative Mtb burden in infected phagocytes. Single-cell RNA sequencing reveals cytotoxic effector-memory programmes and expression of antimicrobial molecules, providing a mechanistic basis for these responses. Together, these findings define a human CD1c-restricted T-cell response to Mtb-infected APCs and identify autoreactive CD1c-restricted T-cells as a candidate cellular axis for lipid-directed immunity in TB.</description>
      <author>s.mansour@soton.ac.uk (Alasdair Leslie)</author>
      <author>s.mansour@soton.ac.uk (Alex Look)</author>
      <author>s.mansour@soton.ac.uk (Andres Vallejo)</author>
      <author>s.mansour@soton.ac.uk (Andrew White)</author>
      <author>s.mansour@soton.ac.uk (Daniel Burns)</author>
      <author>s.mansour@soton.ac.uk (David K Cole)</author>
      <author>s.mansour@soton.ac.uk (Diana Garay-Baquero)</author>
      <author>s.mansour@soton.ac.uk (Jennie Gullick)</author>
      <author>s.mansour@soton.ac.uk (Kinga Niedobecka)</author>
      <author>s.mansour@soton.ac.uk (Laura Denney)</author>
      <author>s.mansour@soton.ac.uk (Liku Tezera)</author>
      <author>s.mansour@soton.ac.uk (Marco Lepore)</author>
      <author>s.mansour@soton.ac.uk (Matthew Milton)</author>
      <author>s.mansour@soton.ac.uk (Patrick Trimby-Smith)</author>
      <author>s.mansour@soton.ac.uk (Paul Elkington)</author>
      <author>s.mansour@soton.ac.uk (Richard Stopforth)</author>
      <author>s.mansour@soton.ac.uk (Rita Szoke-Kovacs)</author>
      <author>s.mansour@soton.ac.uk (Sahar H Farag)</author>
      <author>s.mansour@soton.ac.uk (Salah Mansour)</author>
      <author>s.mansour@soton.ac.uk (Sally Sharpe)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.110341</guid>
      <category>Immunology and Inflammation</category>
      <category>Microbiology and Infectious Disease</category>
      <pubDate>Mon, 05 Oct 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-10-05T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Linear antibody epitope prediction using AlphaFold2</title>
      <link>https://elifesciences.org/articles/98369</link>
      <description>Defining the binding epitopes of antibodies is essential for understanding how they bind to their antigens and perform their molecular functions. However, while determining linear epitopes of monoclonal antibodies can be accomplished utilizing well-established empirical procedures, these approaches are generally labor- and time-intensive, and costly. To take advantage of the recent advances in protein structure prediction algorithms available to the scientific community, we developed a calculation pipeline based on the localColabFold implementation of AlphaFold2 that can predict linear antibody epitopes by predicting the structure of the complex between antibody heavy and light chains and target peptide sequences derived from antigens. We found that this AlphaFold2 pipeline, which we call PAbFold, was able to accurately flag known epitope sequences for several well-known antibody targets (HA/Myc) when the target sequence was broken into small overlapping linear peptides and antibody complementarity determining regions were grafted onto several different antibody framework regions in the single-chain antibody fragment format. To determine if this pipeline was able to identify the epitope of a novel antibody with no structural information publicly available, we determined the epitope of a novel anti-SARS-CoV-2 nucleocapsid-targeted antibody using our method and then experimentally validated our computational results using peptide competition ELISA assays. These results indicate that the AlphaFold2-based PAbFold pipeline we developed is capable of accurately identifying linear antibody epitopes in a short time using just antibody and target protein sequences. This emergent capability of the method is sensitive to methodological details such as peptide length, AlphaFold2 neural network versions, and multiple-sequence alignment databases. PAbFold is available at &lt;a href="https://github.com/jbderoo/PAbFold"&gt;https://github.com/jbderoo/PAbFold&lt;/a&gt;.</description>
      <author>christopher.snow@colostate.edu (Brian J Geiss)</author>
      <author>christopher.snow@colostate.edu (Christopher Snow)</author>
      <author>christopher.snow@colostate.edu (Jacob DeRoo)</author>
      <author>christopher.snow@colostate.edu (James S Terry)</author>
      <author>christopher.snow@colostate.edu (Ning Zhao)</author>
      <author>christopher.snow@colostate.edu (Timothy J Stasevich)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.98369</guid>
      <category>Computational and Systems Biology</category>
      <category>Immunology and Inflammation</category>
      <pubDate>Fri, 18 Sep 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-09-18T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>DGKα and ζ deficiency causes regulatory T-cell dysregulation, destabilization, and conversion to pathogenic T-follicular helper cells to trigger IgG1-predominant autoimmunity</title>
      <link>https://elifesciences.org/articles/105212</link>
      <description>Regulatory T cells (Tregs) actively engage in immune suppression to prevent autoimmune diseases, but also inhibit anti-tumor immunity. Although Tregs express a TCR repertoire with relatively high affinities to self, they are normally quite stable, and their inflammatory programs are intrinsically suppressed. We report here that diacylglycerol kinases (DGK) α and ζ are crucial for homeostasis, suppression of proinflammatory programs, and stability of Tregs, and for enforcing their dependence on CD28 costimulatory signal. Treg-specific deficiency of both DGKα and ζ derails signaling, metabolic, and transcriptional programs in Tregs to cause dysregulated phenotypic and functional properties and to unleash conversion to pathogenic exTregs, especially exTreg-T follicular helper (Tfh) 2 cells, leading to uncontrolled effector T cell differentiation, deregulated germinal center B-cell responses, and IgG1/IgE predominant antibodies/autoantibodies, and multiorgan autoimmune diseases. Our data not only illustrate the crucial roles of DGKs in Tregs to maintain self-tolerance, but also unveil a Treg-to-self-reactive-pathogenic-exTreg-Tfh-cell program that is suppressed by DGKs and that could exert broad pathogenic roles in autoimmune diseases if unchecked.</description>
      <author>xiaoping.zhong@duke.edu (Hongxiang Huang)</author>
      <author>xiaoping.zhong@duke.edu (Hongxia Wang)</author>
      <author>xiaoping.zhong@duke.edu (Huishan Tao)</author>
      <author>xiaoping.zhong@duke.edu (John Sleasman)</author>
      <author>xiaoping.zhong@duke.edu (Lei Li)</author>
      <author>xiaoping.zhong@duke.edu (Michael B Fessler)</author>
      <author>xiaoping.zhong@duke.edu (Peer Karmaus)</author>
      <author>xiaoping.zhong@duke.edu (Shimeng Zhang)</author>
      <author>xiaoping.zhong@duke.edu (Xiao-Ping Zhong)</author>
      <author>xiaoping.zhong@duke.edu (Yun Pan)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.105212</guid>
      <category>Immunology and Inflammation</category>
      <pubDate>Fri, 18 Sep 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-09-18T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>+Clonal stochasticity in early NK cell response to mouse cytomegalovirus is generated by mature subsets of varying proliferative ability</title>
      <link>https://elifesciences.org/articles/104951</link>
      <description>Natural killer (NK) cells are classically defined as innate immune cells, but experiments show that mouse cytomegalovirus (MCMV) infection in C57BL/6 mice can cause NK cells to undergo antigen-specific proliferation and memory formation, similar to adaptive CD8+ T cells. One shared behavior between CD8+ T cells and NK cells is clonal expansion, where a single stimulated cell proliferates rapidly to form a diverse population of cells. For example, clones derived from single cells are most abundant during expansion when they are primarily CD27- for NK cells and CD62L- for T cells, phenotypes derived from precursor CD27+ and CD62L + cells, respectively. Here we determined the mechanistic rules involving proliferation, cell death, and differentiation of endogenous and adoptively transferred NK cells in the expansion phase of the response to MCMV infection. We found that the interplay between cell proliferation and cell death of mature CD27- NK cells and a highly proliferative CD27-Ly6C- mature subtype and intrinsic stochastic fluctuations in these processes play key roles in regulating the heterogeneity and population of the NK cell subtypes. Furthermore, we estimate rates for maturation of endogenous NK cells in homeostasis and in MCMV infection and found that only NK cell growth rates, and not differentiation rates, are appreciably increased by MCMV. Taken together, these results quantify the differences between the kinetics of NK cell antigen-specific expansion from that of CD8+T cells and unique mechanisms that give rise to the observed heterogeneity in NK cell clones generated from single NK cells in the expansion phase.</description>
      <author>darren.wethington@nationwidechildrens.org (Darren Wethington)</author>
      <author>darren.wethington@nationwidechildrens.org (Giuseppe Giuliani)</author>
      <author>darren.wethington@nationwidechildrens.org (Jayajit Das)</author>
      <author>darren.wethington@nationwidechildrens.org (Joseph C Sun)</author>
      <author>darren.wethington@nationwidechildrens.org (Lewis L Lanier)</author>
      <author>darren.wethington@nationwidechildrens.org (Maheshwor Poudel)</author>
      <author>darren.wethington@nationwidechildrens.org (Marc Potempa)</author>
      <author>darren.wethington@nationwidechildrens.org (Nicholas M Adams)</author>
      <author>darren.wethington@nationwidechildrens.org (Oscar A Aguilar)</author>
      <author>darren.wethington@nationwidechildrens.org (Saeed Ahmad)</author>
      <author>darren.wethington@nationwidechildrens.org (Simon Grassmann)</author>
      <author>darren.wethington@nationwidechildrens.org (William C Stewart)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.104951</guid>
      <category>Computational and Systems Biology</category>
      <category>Immunology and Inflammation</category>
      <pubDate>Mon, 14 Sep 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-09-14T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>The C3–C3aR axis modulates trained immunity in alveolar macrophages</title>
      <link>https://elifesciences.org/articles/104977</link>
      <description>Complement protein C3 is crucial for immune responses in mucosal sites such as the lung, where it aids in microbe elimination, and enhances inflammation. While trained immunity – enhanced secondary responses of innate immune cells after prior exposure – is well-studied, the role of the complement system in trained immune responses remains unclear. We investigated the role of C3 in trained immunity and found that alveolar macrophage (AM) &lt;i&gt;C3&lt;/i&gt; and &lt;i&gt;C3aR1&lt;/i&gt; expression increased in humans after an intranasal exposure to a training stimulus. In vivo, trained wild-type mice showed significantly elevated proinflammatory cytokines and increased C3a levels upon a second stimulus. Ex vivo, trained C3-deficient AMs displayed reduced chemokine and cytokine output as well as impaired phagocytosis and reactive oxygen species production compared to wild-type AMs. Real-time confocal microscopy of live, intact mouse alveoli revealed that AMs internalize C3 rapidly after alveolar microinstillation, as compared to C3a. Correspondingly, the blunted cytokine output was restored by exogenous C3 but not by C3a. Inhibiting C3aR, both pharmacologically and with a genetic C3aR knockout, prevented this restoration, indicating the necessity of C3aR engagement. Mechanistically, trained WT AMs demonstrated enhanced glycolytic activity compared to C3-deficient AMs – a defect corrected by exogenous C3 in a C3aR-dependent manner. These findings reveal that C3 modulates trained immunity in AMs through C3aR signaling and highlight a novel role for C3 in trained immunity.</description>
      <author>alexander.earhart@wustl.edu (Aasritha Nallapu)</author>
      <author>alexander.earhart@wustl.edu (Alberto E Lopez)</author>
      <author>alexander.earhart@wustl.edu (Alexander P Earhart)</author>
      <author>alexander.earhart@wustl.edu (Ayse Naz Ozanturk)</author>
      <author>alexander.earhart@wustl.edu (Brian Yang)</author>
      <author>alexander.earhart@wustl.edu (Deebly Chavez)</author>
      <author>alexander.earhart@wustl.edu (Hrishikesh S Kulkarni)</author>
      <author>alexander.earhart@wustl.edu (Jae Woo Lee)</author>
      <author>alexander.earhart@wustl.edu (Jaime Hook)</author>
      <author>alexander.earhart@wustl.edu (Jeffrey Haspel)</author>
      <author>alexander.earhart@wustl.edu (Josue I Hernandez)</author>
      <author>alexander.earhart@wustl.edu (Jungheun Hyun)</author>
      <author>alexander.earhart@wustl.edu (Lorena Garnica)</author>
      <author>alexander.earhart@wustl.edu (Marick Starick)</author>
      <author>alexander.earhart@wustl.edu (Rafael Aponte Alburquerque)</author>
      <author>alexander.earhart@wustl.edu (Rahul Kumar Maurya)</author>
      <author>alexander.earhart@wustl.edu (Sayahi Suthakaran)</author>
      <author>alexander.earhart@wustl.edu (Xiaobo Wu)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.104977</guid>
      <category>Immunology and Inflammation</category>
      <category>Microbiology and Infectious Disease</category>
      <pubDate>Thu, 10 Sep 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-09-10T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Concerted changes in the pediatric single-cell intestinal ecosystem before and after anti-TNF blockade</title>
      <link>https://elifesciences.org/articles/91792</link>
      <description>Crohn’s disease is an inflammatory bowel disease (IBD) commonly treated through anti-TNF blockade. However, most patients still relapse and inevitably progress. Comprehensive single-cell RNA-sequencing (scRNA-seq) atlases have largely sampled patients with established treatment-refractory IBD, limiting our understanding of which cell types, subsets, and states at diagnosis anticipate disease severity and response to treatment. Here, through combining clinical, flow cytometry, histology, and scRNA-seq methods, we profile diagnostic human biopsies from the terminal ileum of treatment-naive pediatric patients with Crohn’s disease (pediCD; &lt;i&gt;n&lt;/i&gt; = 14), matched repeat biopsies (pediCD-treated; &lt;i&gt;n&lt;/i&gt; = 8) and from non-inflamed pediatric controls with functional gastrointestinal disorders (FGIDs; &lt;i&gt;n&lt;/i&gt; = 13). To resolve and annotate epithelial, stromal, and immune cell states among the 201,883 baseline single-cell transcriptomes, we develop a principled and unbiased tiered clustering approach, ARBOL. Through flow cytometry and scRNA-seq, we observe that treatment-naive pediCD and FGID have similar broad cell type composition. However, through high-resolution scRNA-seq analysis and microscopy, we identify significant differences in cell subsets and states that arise during pediCD relative to FGID. By closely linking our scRNA-seq analysis with clinical meta-data, we resolve a vector of T cell, innate lymphocyte, myeloid, and epithelial cell states in treatment-naive pediCD (pediCD-TIME) samples, which can distinguish patients along the trajectory of disease severity and anti-TNF response. By using ARBOL with integration, we position repeat on-treatment biopsies from our patients between treatment-naive pediCD and on-treatment adult CD. We identify that anti-TNF treatment pushes the pediatric cellular ecosystem toward an adult, more treatment-refractory state. Our study jointly leverages a treatment-naive cohort, high-resolution principled scRNA-seq data analysis, and clinical outcomes to understand which baseline cell states may predict Crohn’s disease trajectory.</description>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Alexandre Albanese)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Alex K Shalek)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Alison Yu)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Andrea Hooper)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Andrew C Kwong)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Baijun Kou)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Benjamin A Doran)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Brandi Bratrude)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Conner Kummerlowe)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Connor McGuckin)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Dale Lee)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (David L Suskind)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Faith Taliaferro)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Gail H Deutsch)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (George D Kalliolias)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Ghassan Wahbeh)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Hengqi Betty Zheng)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Jose Ordovas-Montanes)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Joshua de Sousa Casal)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Kayla Betz)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Kayla Cribbin)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Kyle Kimler)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Lauren V Collen)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Leslie S Kean)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Lorenzo Cagnin)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Lusine Ambartsumyan)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Madeline Ford)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Maria Sacta)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Matthew F Wipperman)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Michael Dobosz)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Nathalie Fiaschi)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Paula Keskula)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Ruben van Esch)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Ryan Fleming)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Sandra Coetzee)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Sara C Hamon)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Scott B Snapper)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Sokol Haxhinasto)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Sumreen Jalal)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Vanessa Mitsialis)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Veronika Niederlova)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Victor Tkachev)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Wei Keat Lim)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Xuemei Deng)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Yi Wei)</author>
      <author>jose.ordovas-montanes@childrens.harvard.edu (Yoko Yabe)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.91792</guid>
      <category>Immunology and Inflammation</category>
      <category>Medicine</category>
      <pubDate>Tue, 01 Sep 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-09-01T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Correction: p16 deficiency attenuates intervertebral disc degeneration by adjusting oxidative stress and nucleus pulposus cell cycle</title>
      <link>https://elifesciences.org/articles/112978</link>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.112978</guid>
      <category>Immunology and Inflammation</category>
      <category>Medicine</category>
      <pubDate>Fri, 21 Aug 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-08-21T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>MOTS-c is a mitochondrial-encoded interferon-linked host defense peptide</title>
      <link>https://elifesciences.org/articles/87615</link>
      <description>The mitochondrial DNA (mtDNA) can trigger immune responses and directly entrap pathogens, but it is not known to encode active immune factors. The immune system is traditionally thought to be exclusively nuclear-encoded. Here, we report the identification of a host defense peptide (HDP) encoded in the human mitochondrial genome that presumably derives from the primordial proto-mitochondrial bacteria. We demonstrate that MOTS-c (mitochondrial open reading frame from the 12 S rRNA type-c) is a mitochondrial-encoded amphipathic and cationic peptide with direct antibacterial and immunomodulatory functions, consistent with the peptide chemistry and functions of known HDPs. MOTS-c targeted &lt;i&gt;Escherichia coli&lt;/i&gt; and methicillin-resistant &lt;i&gt;Staphylococcus aureus&lt;/i&gt; (MRSA), in part, by targeting their membranes using its hydrophobic and cationic domains. In a mouse model of acute peritonitis, MOTS-c fully neutralized MRSA infectivity. In human monocytes, interferon gamma (IFNγ), lipopolysaccharides (LPS), and differentiation signals each induced the expression of endogenous MOTS-c. Notably, exogenous MOTS-c, applied during primary mouse monocyte differentiation, reprogrammed the cells into macrophages with distinct transcriptomic signatures related to antigen presentation and IFN signaling. MOTS-c-programmed macrophages exhibited enhanced bacterial clearance and shifted metabolism. Our findings support MOTS-c as a first-in-class mitochondrial-encoded HDP and indicate that our immune system is not only encoded by the nuclear genome but also by the co-evolved mitochondrial genome.</description>
      <author>berenice.benayoun@usc.edu (Bérénice A Benayoun)</author>
      <author>berenice.benayoun@usc.edu (Casey R Barr)</author>
      <author>berenice.benayoun@usc.edu (Changhan Lee)</author>
      <author>berenice.benayoun@usc.edu (Chan Yoon Park)</author>
      <author>berenice.benayoun@usc.edu (Emmeline Kim)</author>
      <author>berenice.benayoun@usc.edu (Ilana Cohen)</author>
      <author>berenice.benayoun@usc.edu (Jessica S Kim)</author>
      <author>berenice.benayoun@usc.edu (Jyung Mean Son)</author>
      <author>berenice.benayoun@usc.edu (Kathleen Tor)</author>
      <author>berenice.benayoun@usc.edu (Maria Imun)</author>
      <author>berenice.benayoun@usc.edu (Michelle C Rice)</author>
      <author>berenice.benayoun@usc.edu (Rochelle W Lai)</author>
      <author>berenice.benayoun@usc.edu (Ryan J Lu)</author>
      <author>berenice.benayoun@usc.edu (Sang Wun Jung)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.87615</guid>
      <category>Cell Biology</category>
      <category>Immunology and Inflammation</category>
      <pubDate>Tue, 18 Aug 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-08-18T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>TLR4 signaling drives tissue inflammation, Claudin-5 internalization, and vascular barrier breakdown in a mouse model of neonatal meningitis</title>
      <link>https://elifesciences.org/articles/110458</link>
      <description>Neonatal bacterial meningitis is a leading cause of infant morbidity and mortality, yet the molecular and cellular basis of the leptomeningeal response to infection remains poorly defined. Here, we study a mouse model of neonatal &lt;i&gt;Escherichia coli&lt;/i&gt; meningitis, combining conditional gene knockouts, leptomeningeal single-nucleus RNA sequencing, and endothelial cell culture to explore the role of Toll-like receptor 4 (TLR4) signaling in the host response to infection. Deletion of &lt;i&gt;Tlr4&lt;/i&gt; in non-myeloid cells dramatically reduced the inflammatory response in all leptomeningeal cell types and abrogated the infection-associated increase in vascular permeability. In a brain endothelial cell line (bEnd.3 cells), exposure to &lt;i&gt;E. coli&lt;/i&gt; triggered NF-κB activation, selective internalization of Claudin-5, and increased monolayer permeability, responses that were eliminated by &lt;i&gt;Tlr4&lt;/i&gt; knockout. RNA-seq showed that TLR4 controls an NF-κB–driven transcriptional program that orchestrates the endothelial response to &lt;i&gt;E. coli&lt;/i&gt;. These findings reveal multiple TLR4-dependent host responses to neonatal Gram-negative bacterial meningitis.</description>
      <author>jnathans@jhmi.edu (Amir Rattner)</author>
      <author>jnathans@jhmi.edu (Jeremy Nathans)</author>
      <author>jnathans@jhmi.edu (Philip M Smallwood)</author>
      <author>jnathans@jhmi.edu (Philip V Seegren)</author>
      <author>jnathans@jhmi.edu (Yanshu Wang)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.110458</guid>
      <category>Immunology and Inflammation</category>
      <pubDate>Tue, 18 Aug 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-08-18T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>ImPaqT, a Golden Gate-based immunological toolkit for zebrafish transgenesis</title>
      <link>https://elifesciences.org/articles/104182</link>
      <description>Transgenic animals play an essential role in many aspects of zebrafish research. Here, we have developed ImPaqT (&lt;b&gt;Im&lt;/b&gt;munological Toolkit for &lt;b&gt;Paq&lt;/b&gt;CI-based Golden Gate Assembly of Tol2 &lt;b&gt;T&lt;/b&gt;ransgenes), a new Tol2-based transgenesis system that utilizes Golden Gate assembly to facilitate the production of transgenic zebrafish lines. This system allows for rapid assembly of multiple fragments into a single transgene, facile swapping of individual sequences to generate new transgenes, and an easy cloning workflow to incorporate new genetic elements into the existing kit. Within this framework, we have generated reagents to enable gene expression within different cell types, an array of best-in-class fluorescent proteins to visualize cell populations and transgenes, as well as tools to simplify genetic manipulation, purification, and ablation of targeted cells. Unlike many recombination-based systems, our approach is also expandable, allowing the incorporation of complex designs such as multifragment promoters within the established modular framework of ImPaqT. We have demonstrated the function of our system by generating various transgenic immune reporter lines. While we focused on the immune system as an emerging area of study within zebrafish research, ImPaqT can be broadly adapted to the construction of almost any zebrafish transgene, offering new tools for the zebrafish community.</description>
      <author>cronan@mpiib-berlin.mpg.de (Christiane Dimmler)</author>
      <author>cronan@mpiib-berlin.mpg.de (Mark R Cronan)</author>
      <author>cronan@mpiib-berlin.mpg.de (Saskia Hurst)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.104182</guid>
      <category>Immunology and Inflammation</category>
      <pubDate>Wed, 29 Jul 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-07-29T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Reprogramming of host energy metabolism mediated by the TNF-iNOS-HIF-1α axis plays a key role in host resistance to &lt;i&gt;Plasmodium&lt;/i&gt; infection</title>
      <link>https://elifesciences.org/articles/97759</link>
      <description>TNF has a dual effect in &lt;i&gt;Plasmodium&lt;/i&gt; infection, bolstering the host's immune defense while also inducing sickness behavior. Here, we confirm that TNF signaling hampers physical activity, food intake, and energy expenditure while enhancing glucose uptake by the liver and spleen, as well as controlling parasitemia in &lt;i&gt;Plasmodium chabaudi&lt;/i&gt; (&lt;i&gt;Pc&lt;/i&gt;)-infected mice. We also report that TNF is required for expression of inducible nitric oxide synthase (iNOS), stabilization of hypoxia-inducible factor 1α (HIF-1α), expression of glucose transporter GLUT1, and enhanced glycolysis in monocytic cells from &lt;i&gt;Pc&lt;/i&gt;-infected mice. Importantly, &lt;i&gt;Pc&lt;/i&gt;-infected &lt;i&gt;Nos2&lt;/i&gt;&lt;sup&gt;-/-&lt;/sup&gt;, TNFR1 cKO, and HIF-1a cKO mice show impaired release of TNF and glycolysis in monocytes, along with increased parasitemia and disease tolerance. Altogether, our results indicate that TNF-iNOS-HIF-1α-induced glycolysis in monocytes plays a critical role in host defense and sickness behavior in &lt;i&gt;Pc&lt;/i&gt;-infected mice.</description>
      <author>kelycatarine@gmail.com (Diego Luis Costa)</author>
      <author>kelycatarine@gmail.com (Franciele Pioto)</author>
      <author>kelycatarine@gmail.com (Isabella Cristina Hirako)</author>
      <author>kelycatarine@gmail.com (João S da Silva)</author>
      <author>kelycatarine@gmail.com (José C Alves-Filho)</author>
      <author>kelycatarine@gmail.com (Juliana E Toller-Kawahisa)</author>
      <author>kelycatarine@gmail.com (Kely Catarine Matteucci)</author>
      <author>kelycatarine@gmail.com (Leonardo Gomes Vaz)</author>
      <author>kelycatarine@gmail.com (Nathalia PS Leite)</author>
      <author>kelycatarine@gmail.com (Ogooluwa Ojelabi)</author>
      <author>kelycatarine@gmail.com (Patricia A Assis)</author>
      <author>kelycatarine@gmail.com (Ricardo T Gazzinelli)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.97759</guid>
      <category>Immunology and Inflammation</category>
      <category>Microbiology and Infectious Disease</category>
      <pubDate>Mon, 27 Jul 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-07-27T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Heterozygote advantage cannot explain MHC diversity, but MHC diversity can explain heterozygote advantage</title>
      <link>https://elifesciences.org/articles/107256</link>
      <description>Several theoretical studies have concluded that heterozygote advantage makes at most a minor contribution to MHC diversity. Siljestam and Rueffler (2024) recently presented models in which heterozygote advantage alone can lead to realistically high diversity. Here I argue that heterozygote advantage cannot by itself explain MHC diversity, and that its contribution to diversity is unlikely to be large in most species. I first show that the high diversity reported by Siljestam and Rueffler is so sensitive to parameter values that the underlying phenomenon cannot explain the widespread diversity of MHC genes. I then consider a fundamental problem with explaining MHC diversity by heterozygote advantage alone: selective forces that favored heterozygotes would lead to the evolution of haplotypes having much higher fitness when homozygous, diminishing or eliminating heterozygote advantage. Diversity maintained by another force, however, might bring about adaptation to the more common heterozygous state at the expense of homozygous fitness. Thus, substantial heterozygote advantage may arise as a consequence of MHC diversity.</description>
      <author>jcherry@ncbi.nlm.nih.gov (Joshua L Cherry)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.107256</guid>
      <category>Evolutionary Biology</category>
      <category>Immunology and Inflammation</category>
      <pubDate>Mon, 13 Jul 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-07-13T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Depletion of extracellular asparagine impairs self-reactive T cells and ameliorates autoimmunity in a murine model of multiple sclerosis</title>
      <link>https://elifesciences.org/articles/107745</link>
      <description>Amino acids play critical roles in the activation and function of lymphocytes. Here we show that the non-essential amino acid, asparagine, is essential for optimal activation and proliferation of CD4&lt;sup&gt;+&lt;/sup&gt; T cells. We demonstrate that asparagine depletion at different time points after CD4&lt;sup&gt;+&lt;/sup&gt; T cell activation reduces mitochondrial membrane potential and function. Furthermore, asparagine depletion at specific time points during CD4&lt;sup&gt;+&lt;/sup&gt; T cell differentiation reduces cytokine production in multiple CD4&lt;sup&gt;+&lt;/sup&gt; T cell subsets. In an adoptive transfer model of experimental autoimmune encephalomyelitis (EAE), myelin oligodendrocyte-specific pathogenic T helper 17 cells differentiated under Asn-deficient conditions exhibited reduced encephalitogenic potential and attenuated EAE severity. In a model of EAE induced by active immunization, therapeutic depletion of extracellular Asn significantly reduced disease severity. These results identify asparagine as a key metabolic regulator of the pathogenicity of autoreactive CD4&lt;sup&gt;+&lt;/sup&gt; T cells and suggest that targeting asparagine metabolism may be a novel therapeutic strategy for autoimmunity.</description>
      <author>marcia_haigis@hms.harvard.edu (Arlene H Sharpe)</author>
      <author>marcia_haigis@hms.harvard.edu (Dan Liang)</author>
      <author>marcia_haigis@hms.harvard.edu (Dillon Patterson)</author>
      <author>marcia_haigis@hms.harvard.edu (Hannah Creasey)</author>
      <author>marcia_haigis@hms.harvard.edu (Jared Rowe)</author>
      <author>marcia_haigis@hms.harvard.edu (Kiran Kurmi)</author>
      <author>marcia_haigis@hms.harvard.edu (Linglin Huang)</author>
      <author>marcia_haigis@hms.harvard.edu (Marcia C Haigis)</author>
      <author>marcia_haigis@hms.harvard.edu (Naomi Goldman)</author>
      <author>marcia_haigis@hms.harvard.edu (Peter Georgiev)</author>
      <author>marcia_haigis@hms.harvard.edu (SeongJun Han)</author>
      <author>marcia_haigis@hms.harvard.edu (Sheila Johnson)</author>
      <author>marcia_haigis@hms.harvard.edu (Song-Hua Hu)</author>
      <author>marcia_haigis@hms.harvard.edu (Thao H Nguyen)</author>
      <author>marcia_haigis@hms.harvard.edu (Thomas Conway)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.107745</guid>
      <category>Immunology and Inflammation</category>
      <pubDate>Wed, 08 Jul 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-07-08T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Celldetective, an AI-enhanced image analysis tool for unraveling dynamic cell interactions</title>
      <link>https://elifesciences.org/articles/105302</link>
      <description>Analysis of multimodal and multidimensional data capturing dynamic interactions between diverse cell populations is a current challenge in bioimaging, especially in the context of immunology and immunotherapy research. Here, we introduce Celldetective, an open-source Python-based software tool designed for high-performance end-to-end analysis of image-based in vitro immune and immunotherapy assays. Celldetective is purpose-built for multicondition, 2D multi-channel time-lapse microscopy of mixed cell populations. Although it is optimised for the needs of immunology assays, it is nevertheless broadly applicable to any biological system involving interacting cell populations. The software seamlessly integrates AI-based segmentation, tracking, and automated single-cell event detection, all within an intuitive graphical interface that supports interactive visualisation, annotation, and training options. We showcase its capabilities with original datasets of single immune effector cell interactions with an activating surface mediated by bispecific antibodies and pairwise interactions in antibody-dependent cell cytotoxicity events.</description>
      <author>remy.torro@gmail.com (Beatriz Díaz-Bello)</author>
      <author>remy.torro@gmail.com (Dalia El Arawi)</author>
      <author>remy.torro@gmail.com (Florian Dupuy)</author>
      <author>remy.torro@gmail.com (Kheya Sengupta)</author>
      <author>remy.torro@gmail.com (Ksenija Dervanova)</author>
      <author>remy.torro@gmail.com (Laurent Limozin)</author>
      <author>remy.torro@gmail.com (Lorna Ammer)</author>
      <author>remy.torro@gmail.com (Patrick Chames)</author>
      <author>remy.torro@gmail.com (Rémy Torro)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.105302</guid>
      <category>Computational and Systems Biology</category>
      <category>Immunology and Inflammation</category>
      <pubDate>Wed, 08 Jul 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-07-08T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>TGF-β drives the conversion of conventional NK cells into uterine tissue-resident NK cells to support murine pregnancy</title>
      <link>https://elifesciences.org/articles/109878</link>
      <description>Tissue microenvironments shape lymphocyte differentiation to align immune function with local physiological demands. Uterine natural killer (NK) cells are critical for reproductive success, yet the molecular cues in the uterus that instruct their specialized identities remain incompletely understood. Here, we identify a TGF-β-dependent differentiation pathway by which circulating conventional NK cells convert into uterine tissue-resident NK cells during murine pregnancy. Loss of TGF-β receptor II expression in &lt;i&gt;Ncr1&lt;/i&gt;-expressing cells disrupted this conversion, markedly reducing tissue-resident NK cells in the gravid uterus. Impaired TGF-β-driven uterine tissue-resident NK cell differentiation during murine pregnancy led to abnormal spiral artery remodeling and increased fetal resorption rates at mid-gestation, ultimately reducing litter sizes at birth. Collectively, these findings define TGF-β as a pivotal driver of tissue-resident NK cell differentiation in the gravid uterus and establish a mechanistic framework through which the uterine microenvironment programs NK cell identity to meet the physiological demands of gestation.</description>
      <author>yokoyama@wustl.edu (D Michael Nelson)</author>
      <author>yokoyama@wustl.edu (Josselyn D Barahona)</author>
      <author>yokoyama@wustl.edu (Liping Yang)</author>
      <author>yokoyama@wustl.edu (Wayne M Yokoyama)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.109878</guid>
      <category>Immunology and Inflammation</category>
      <pubDate>Wed, 08 Jul 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-07-08T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Cribriform plate microenvironment assembles a suppressive myeloid network during EAE-induced neuroinflammation</title>
      <link>https://elifesciences.org/articles/110460</link>
      <description>During neuroinflammation, CD11c&lt;sup&gt;+&lt;/sup&gt;CD11b&lt;sup&gt;+&lt;/sup&gt; myeloid cells accumulate at the cribriform plate, a key cerebrospinal fluid and antigen outflow site in mice. At this site, podoplanin-expressing cells, including lymphatic vessels and meningeal layers, expand to create a distinct drainage microenvironment. In this study, we sought to characterize myeloid cells, which populate this region, using a mouse model of neuroinflammation, experimental autoimmune encephalomyelitis. Utilizing a combination of immunohistochemistry, flow cytometry, and scRNAseq, we report that macrophages and dendritic cells from this region display unique expressional signatures related to tolerance, cell death, and reduced inflammatory profile. Together, this data supports that myeloid retention at the cribriform plate and olfactory bulb meninges promotes a local immunosuppressive environment.</description>
      <author>zfabry@wisc.edu (Andy Madrid)</author>
      <author>zfabry@wisc.edu (Cameron Baenen)</author>
      <author>zfabry@wisc.edu (Collin Laaker)</author>
      <author>zfabry@wisc.edu (Jenna Port)</author>
      <author>zfabry@wisc.edu (Martin Hsu)</author>
      <author>zfabry@wisc.edu (Matyas Sandor)</author>
      <author>zfabry@wisc.edu (Melinda Herbath)</author>
      <author>zfabry@wisc.edu (Mohan Kumar)</author>
      <author>zfabry@wisc.edu (Sophia M Vrba)</author>
      <author>zfabry@wisc.edu (Thanthrige Thiunuwan Priyathilaka)</author>
      <author>zfabry@wisc.edu (Zsuzsanna Fabry)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.110460</guid>
      <category>Immunology and Inflammation</category>
      <category>Neuroscience</category>
      <pubDate>Wed, 08 Jul 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-07-08T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Pink1-mediated mitophagy in the endothelium releases proteins encoded by mitochondrial DNA and activates neutrophil responses during inflammation</title>
      <link>https://elifesciences.org/articles/82205</link>
      <description>Eukaryotic mitochondria are characterized by several features that represent vestiges of their prokaryotic ancestry. One such feature is the N-terminal formylation of proteins encoded by mitochondrial DNA that undergo translation by mitochondrial ribosomes. N-formylated proteins are also released by bacteria and trigger activation of immune cells, such as neutrophils. Growing evidence indicates that circulating levels of mitochondrial formyl proteins are elevated in the serum of patients with excessive inflammatory responses. However, the mechanisms by which they are released into circulation are not known. In this study, we have identified vascular endothelial cells as a source of Pink1-dependent release of mitochondrial formyl proteins in response to inflammatory mediators. Mechanistically, the mitophagy mediator Pink1 is stabilized by inflammatory activation of endothelial cells, promoting mitophagy and mitochondrial formyl peptide release both in mice and primary human endothelial cells. Using nanoparticle delivery of &lt;i&gt;Pink1&lt;/i&gt;-targeting sgRNA in mice expressing endothelial-specific Cas9, we developed a mouse model in which &lt;i&gt;Pink1&lt;/i&gt; is specifically depleted in the endothelium. Deletion of endothelial &lt;i&gt;Pink1&lt;/i&gt; decreased circulating formyl peptide levels, lowered lung neutrophil infiltration, and reduced mortality in mice. We thus propose that endothelial cells upregulate pro-inflammatory mitophagy in response to inflammation, leading to the release of mitochondrial formyl peptides and detrimental neutrophil recruitment into the lung.</description>
      <author>jalees@uic.edu (Chinnaswamy Tiruppathi)</author>
      <author>jalees@uic.edu (Dong-Mei Wang)</author>
      <author>jalees@uic.edu (Jalees Rehman)</author>
      <author>jalees@uic.edu (Koushik Debnath)</author>
      <author>jalees@uic.edu (Li Wang)</author>
      <author>jalees@uic.edu (Peter T Toth)</author>
      <author>jalees@uic.edu (Pierina Danos)</author>
      <author>jalees@uic.edu (Priyanka Gajwani)</author>
      <author>jalees@uic.edu (Sarah Krantz)</author>
      <author>jalees@uic.edu (Shubhi Srivastava)</author>
      <author>jalees@uic.edu (Sriram Ravindran)</author>
      <author>jalees@uic.edu (Young-Mee Kim)</author>
      <author>jalees@uic.edu (Zijing Ye)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.82205</guid>
      <category>Cell Biology</category>
      <category>Immunology and Inflammation</category>
      <pubDate>Wed, 01 Jul 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-07-01T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Direct contact between iPSC-derived macrophages and hepatocytes drives reciprocal acquisition of Kupffer cell identity and hepatocyte maturation</title>
      <link>https://elifesciences.org/articles/108938</link>
      <description>As the resident tissue macrophage of the liver, Kupffer cells (KCs) play an important role in homeostasis and tissue support. However, current in vitro liver models often ignore the contribution of these KCs towards the proper response and function of the tissue. This is especially relevant when we consider the implications of immune-mediated drug injuries. To address this issue, we developed an isogenic co-culture system utilising iPSC-derived macrophages (iMacs) and hepatocytes (iHeps). Directly co-culturing iHeps with iMacs improved the differentiation and maturation of the iHeps, with significant downregulation of fetal hepatocyte markers as well as upregulation of cytochrome genes. Furthermore, the co-culture also imparted stronger KC identity to the iMacs in a contact-dependent manner, with iMacs cultured in iHep conditioned media alone showing weaker expression of key KC markers. Finally, challenging the iHep-iMac co-culture system with seven paradigm hepatotoxic compounds showed dose-dependent cytokine response in the five compounds associated with immune-mediated liver injuries while no significant changes were observed in the two compounds with no reported immune-dependent complications. This effect was also not recapitulated when the co-culture was instead performed with human peripheral blood monocyte-derived macrophages, suggesting that iMacs are essential for liver toxicity response. Taken together, our study shows not only the importance of macrophages in tissue systems, but also that the source of macrophages is critical to the development of accurate in vitro human models.</description>
      <author>phsyuh@nus.edu.sg (Christopher Zhe Wei Lee)</author>
      <author>phsyuh@nus.edu.sg (Farah Tasnim)</author>
      <author>phsyuh@nus.edu.sg (Florent Ginhoux)</author>
      <author>phsyuh@nus.edu.sg (Hanry Yu)</author>
      <author>phsyuh@nus.edu.sg (Ivy Low)</author>
      <author>phsyuh@nus.edu.sg (Jinmiao Chen)</author>
      <author>phsyuh@nus.edu.sg (Nicholas Ang)</author>
      <author>phsyuh@nus.edu.sg (Raman Sethi)</author>
      <author>phsyuh@nus.edu.sg (Sebastiaan De Schepper)</author>
      <author>phsyuh@nus.edu.sg (Tatsuya Kozaki)</author>
      <author>phsyuh@nus.edu.sg (Xiaozhong Huang)</author>
      <author>phsyuh@nus.edu.sg (Yoohyun Song)</author>
      <author>phsyuh@nus.edu.sg (You Yi Hwang)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.108938</guid>
      <category>Immunology and Inflammation</category>
      <pubDate>Mon, 29 Jun 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-06-29T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Correlates of protection against African swine fever virus identified by a systems immunology approach</title>
      <link>https://elifesciences.org/articles/107579</link>
      <description>African swine fever virus (ASFV) causes a fatal hemorrhagic disease in domestic pigs and wild boars, which poses severe threats to the global pork industry. Despite the promise of live attenuated vaccines (LAVs), their narrow margin between efficacy and residual virulence presents major safety challenges. This study bridges a critical knowledge gap in ASF vaccinology by identifying innate and adaptive correlates of protection. This was achieved by using an established model with two groups of pigs differing in baseline immunological status (farm and specific pathogen-free [SPF]). The animals were immunized with an attenuated ASFV strain and subsequently challenged with a related, highly virulent genotype II strain. By applying a systems immunology approach, we correlated kinetic data, including serum cytokines, blood transcription modules (BTMs), T-cell responses, and antibody levels, with clinical outcomes to track protective and detrimental immune responses to the virus over time. Key innate correlates of protection included early and sustained IFN-α response, activation of antigen presentation BTMs, and controlled IL-8 levels during immunization. Lower baseline immune activation observed in SPF pigs in steady state was linked to increased protection. Adaptive correlates encompassed cell cycle, plasma cell, and T-cell BTM responses lasting until day 15 post-immunization. Consequently, an effective response from ASFV-specific T&lt;sub&gt;h&lt;/sub&gt; cells prior to challenge indicated protection. After the challenge, an early IFN-α response, along with low levels of pro-inflammatory cytokines and a strong induction of memory T&lt;sub&gt;h&lt;/sub&gt; and T&lt;sub&gt;c&lt;/sub&gt; cells, correlated with improved clinical outcomes. The model highlights the critical role of host-specific factors in vaccine efficacy and provides a valuable framework for optimizing ASFV vaccine design while distinguishing between protective and detrimental immune responses.</description>
      <author>artur.summerfield@unibe.ch (Artur Summerfield)</author>
      <author>artur.summerfield@unibe.ch (Charaf Benarafa)</author>
      <author>artur.summerfield@unibe.ch (Francisco Brito)</author>
      <author>artur.summerfield@unibe.ch (Kemal Mehinagic)</author>
      <author>artur.summerfield@unibe.ch (Kirill Lotonin)</author>
      <author>artur.summerfield@unibe.ch (Matthias Liniger)</author>
      <author>artur.summerfield@unibe.ch (Nicolas Ruggli)</author>
      <author>artur.summerfield@unibe.ch (Noelle Donzé)</author>
      <author>artur.summerfield@unibe.ch (Obdulio García-Nicolás)</author>
      <author>artur.summerfield@unibe.ch (Stephanie Talker)</author>
      <author>artur.summerfield@unibe.ch (Sylvie Python)</author>
      <author>artur.summerfield@unibe.ch (Tosca Ploegaert)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.107579</guid>
      <category>Immunology and Inflammation</category>
      <category>Microbiology and Infectious Disease</category>
      <pubDate>Mon, 29 Jun 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-06-29T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Deciphering interferon functions in avian influenza using receptor knockout models in the natural host</title>
      <link>https://elifesciences.org/articles/107855</link>
      <description>The rapid cross-species transmission of highly pathogenic avian influenza presents a significant zoonotic threat. Elucidating the avian interferon (IFN) system, the primary antiviral defense in chickens, is critical for controlling the virus at its source and preventing its spillover into humans and other species. We engineered type I (IFN-α/β) and type III (IFN-λ) IFN receptor knockout chickens to dissect the role of IFNs in viral infections. Results revealed that type I IFN predominantly modulates innate immune cell populations, T cell subsets, and their contribution to antibody production following immunization under physiological conditions. In ovo and in vivo challenge experiments utilizing diverse influenza A virus strains demonstrated strain-specific roles of both IFN-α/β and IFN-λ in orchestrating viral pathogenesis, immunological responses, and tissue-tropism effects. Notably, type I IFN was particularly crucial in the initial defense mechanisms against H3N1 avian influenza A virus infection. These novel models offer unprecedented insights into avian IFN biology within the context of avian influenza, which is essential for developing more effective strategies to prevent and control this public health challenge.</description>
      <author>benjamin.schusser@tum.de (Arne Reich)</author>
      <author>benjamin.schusser@tum.de (Bassel Aboukhadra)</author>
      <author>benjamin.schusser@tum.de (Benjamin Schade)</author>
      <author>benjamin.schusser@tum.de (Benjamin Schusser)</author>
      <author>benjamin.schusser@tum.de (Christian Zenner)</author>
      <author>benjamin.schusser@tum.de (Hanna Kaisa Vikkula)</author>
      <author>benjamin.schusser@tum.de (Hicham Sid)</author>
      <author>benjamin.schusser@tum.de (Leora Avolio)</author>
      <author>benjamin.schusser@tum.de (Milena Brunner)</author>
      <author>benjamin.schusser@tum.de (Mohanned Naif Alhussien)</author>
      <author>benjamin.schusser@tum.de (Rashi Negi)</author>
      <author>benjamin.schusser@tum.de (Romina Klinger)</author>
      <author>benjamin.schusser@tum.de (Rudolf Preisinger)</author>
      <author>benjamin.schusser@tum.de (Sabrina Schleibinger)</author>
      <author>benjamin.schusser@tum.de (Silke Rautenschlein)</author>
      <author>benjamin.schusser@tum.de (Simon P Früh)</author>
      <author>benjamin.schusser@tum.de (Theresa von Heyl)</author>
      <author>benjamin.schusser@tum.de (Tom VL Berghof)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.107855</guid>
      <category>Immunology and Inflammation</category>
      <pubDate>Fri, 26 Jun 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-06-26T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Metabolic support of trained immune responses in myeloid cells</title>
      <link>https://elifesciences.org/articles/108814</link>
      <description>Trained immunity (TI) is defined as a form of innate immune memory characterised by a long-lasting ability to develop enhanced responses to a secondary challenge, whether of the same or a different nature than the initial stimulus. This process is mediated by several established hallmarks, most prominently the existence of activating epigenetic marks and metabolic adaptations. The activating epigenetic marks prime the expression of immune-related genes and are a direct driving force behind the increased cytokine production after secondary stimulation of trained monocytes and macrophages. Training stimuli also induce specific metabolic adaptations, such as the upregulation of glycolysis and lactate production or the activation of glutaminolysis leading to fumarate accumulation, which in turn promotes epigenetic changes. However, the mechanisms linking these epigenetic and metabolic changes to a TI phenotype are varied, and not all stimuli that increase glycolysis promote training, whereas some stimuli such as lipopolysaccharide (LPS) display a non-monotonic induction of TI. In addition to metabolism directly driving epigenetic changes, early gene expression changes can also reshape cell metabolism to promote a trained phenotype. In this review we aim to separate two main types of metabolic rewiring that have not been previously uncoupled. Firstly, those primary metabolic changes occurring during the initial stimulation, which precede TI induction by altering the epigenomic landscape around inflammatory genes. Secondly, those metabolic adaptations arising later as a consequence of the first wave of epigenetic regulation, which support an enhanced functional state of macrophages.</description>
      <author>gillian.dunphy@cnic.es (Aitor Jarit-Cabanillas)</author>
      <author>gillian.dunphy@cnic.es (David Sancho)</author>
      <author>gillian.dunphy@cnic.es (Federico Virga)</author>
      <author>gillian.dunphy@cnic.es (Gillian Dunphy)</author>
      <author>gillian.dunphy@cnic.es (Jan Van den Bossche)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.108814</guid>
      <category>Immunology and Inflammation</category>
      <pubDate>Fri, 19 Jun 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-06-19T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Tracheal terminal cells of &lt;i&gt;Drosophila&lt;/i&gt; are immune privileged to maintain their Foxo-dependent structural plasticity</title>
      <link>https://elifesciences.org/articles/102369</link>
      <description>Respiratory organs must balance their primary function of gas exchange with the constant threat of inhaled pathogens. In the &lt;i&gt;Drosophila&lt;/i&gt; tracheal system, gas exchange occurs at the tracheal terminal cells (TTCs), the functional equivalents of mammalian alveoli. While bacterial infection triggers a robust innate immune response throughout the broader airway epithelium, we reveal that TTCs are uniquely exempt from this reaction. Mechanistically, TTCs lack expression of the membrane-associated peptidoglycan recognition receptor PGRP-LC. This absence protects these highly susceptible cells from immune deficiency (Imd) pathway activation and subsequent JNK-mediated cell death, establishing TTCs as a distinct, immune-privileged niche. Ectopic immune activation via targeted &lt;i&gt;PGRP-LCx&lt;/i&gt; overexpression in TTCs caused a severe reduction in branching, cellular damage, and ultimately cell death, phenotypes that were fully rescued by the depletion of AP-1 or &lt;i&gt;foxo&lt;/i&gt;. Because both structural plasticity (in response to nutritional cues and hypoxia) and innate immune responses strictly require the transcription factor FoxO, we demonstrate that potent immune signaling is fundamentally incompatible with dynamic TTC remodeling. Ultimately, the immune-privileged status of TTCs represents an essential evolutionary trade-off, restricting local inflammation to preserve &lt;i&gt;foxo&lt;/i&gt;-dependent structural plasticity and vital respiratory function.</description>
      <author>jbossen@zoologie.uni-kiel.de (Jingjing He)</author>
      <author>jbossen@zoologie.uni-kiel.de (Judith Bossen)</author>
      <author>jbossen@zoologie.uni-kiel.de (Larissa Fritz)</author>
      <author>jbossen@zoologie.uni-kiel.de (Leizhi Shi)</author>
      <author>jbossen@zoologie.uni-kiel.de (Reshmi Raveendran)</author>
      <author>jbossen@zoologie.uni-kiel.de (Thomas Roeder)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.102369</guid>
      <category>Immunology and Inflammation</category>
      <pubDate>Wed, 17 Jun 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-06-17T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Deep mutational scanning reveals pharmacologically relevant insights into TYK2 signaling and disease</title>
      <link>https://elifesciences.org/articles/110149</link>
      <description>Tyrosine kinase 2 (TYK2) is a genetically defined target for autoimmune disease, with first-generation inhibitors showing clinical success in some but not all associated indications. A deeper understanding of TYK2 structure-function relationships, protein-ligand interactions, and the impact of human variants could inform next-generation therapeutics. Here, we applied deep mutational scanning (DMS) to assess &amp;gt;23,000 amino acid substitutions across two TYK2 functions: interferon alpha (IFN-α) signaling and protein abundance. This enabled high-resolution structure-function mapping and the identification of novel allosteric sites. By coupling DMS with inhibitor treatment, we uncovered variants that modulate compound potency. We also show that human variants – both common and rare – that are protective against autoimmune phenotypes reduce TYK2 protein abundance. Together, these findings demonstrate that DMS can prospectively reveal novel druggable sites, clarify structure-activity relationships (SAR), and highlight TYK2 degradation as a potential therapeutic strategy in autoimmunity.</description>
      <author>diane@octant.bio (Abhay Hukku)</author>
      <author>diane@octant.bio (Alan L Su)</author>
      <author>diane@octant.bio (Angela Chan)</author>
      <author>diane@octant.bio (Bryan L Jiang)</author>
      <author>diane@octant.bio (Carmen Resnick)</author>
      <author>diane@octant.bio (Carolindah Ntimi)</author>
      <author>diane@octant.bio (Conor J Howard)</author>
      <author>diane@octant.bio (Diane E Dickel)</author>
      <author>diane@octant.bio (Dora Barbosa Rabago)</author>
      <author>diane@octant.bio (Eden Mahdavi)</author>
      <author>diane@octant.bio (Emily R Holzinger)</author>
      <author>diane@octant.bio (Erin M Thompson)</author>
      <author>diane@octant.bio (Gabriel A Mintier)</author>
      <author>diane@octant.bio (Joseph C Maranville)</author>
      <author>diane@octant.bio (Kaitlyn N Weiler)</author>
      <author>diane@octant.bio (Katrina Catalano)</author>
      <author>diane@octant.bio (Morgan MacKenzie)</author>
      <author>diane@octant.bio (Nabil Mohammed)</author>
      <author>diane@octant.bio (Nathan S Abell)</author>
      <author>diane@octant.bio (Payal R Sheth)</author>
      <author>diane@octant.bio (Robert M Plenge)</author>
      <author>diane@octant.bio (Robert R Warneford-Thomson)</author>
      <author>diane@octant.bio (Sriram Kosuri)</author>
      <author>diane@octant.bio (Stephen C Wilson)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.110149</guid>
      <category>Genetics and Genomics</category>
      <category>Immunology and Inflammation</category>
      <pubDate>Wed, 10 Jun 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-06-10T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Beta-Glucan modulates monocyte plasticity and differentiation capacity to mitigate DSS-induced colitis</title>
      <link>https://elifesciences.org/articles/107339</link>
      <description>Trained immunity involves the reprogramming of innate immune cells after an initial exposure, resulting in heightened inflammatory responses to subsequent stimuli and enhanced bactericidal capacity during infection. However, this pro-inflammatory state could also exacerbate chronic conditions like inflammatory bowel disease (IBD), which is characterized by persistent inflammation and microbial imbalance. It remains unclear how trained immunity influences IBD pathogenesis and whether it can be harnessed therapeutically. In our study, pretreatment with β-glucan reprogrammed bone marrow hematopoietic progenitors and peripheral monocytes, inducing a profound shift in monocyte plasticity and significantly reducing the severity of dextran sulfate sodium (DSS)-induced colitis. Adoptive transfer of bone marrow or peripheral monocytes from β-glucan-trained mice into naive mice conferred robust protection against colitis, demonstrating that this protective effect is transferable. Trained mice also displayed improved clearance of intestinal bacterial infections. Single-cell RNA sequencing revealed an expansion of reparative Cx3cr1&lt;sup&gt;+&lt;/sup&gt; macrophages derived from Ly6C&lt;sup&gt;hi&lt;/sup&gt; monocytes, correlating with accelerated colonic epithelial regeneration. Collectively, these findings reveal how β-glucan-induced trained immunity modulates monocyte differentiation to ameliorate experimental colitis, highlighting the potential of harnessing trained immunity as a therapeutic strategy to recalibrate innate immune responses and restore gut homeostasis in IBD, shedding light for future clinical applications.</description>
      <author>jianlin.ren@126.com (Dan Du)</author>
      <author>jianlin.ren@126.com (Ermei Chen)</author>
      <author>jianlin.ren@126.com (Hongzhi Xu)</author>
      <author>jianlin.ren@126.com (Huaxiu Shi)</author>
      <author>jianlin.ren@126.com (Jianlin Ren)</author>
      <author>jianlin.ren@126.com (Lin Wang)</author>
      <author>jianlin.ren@126.com (Linying Li)</author>
      <author>jianlin.ren@126.com (Qingqi Fan)</author>
      <author>jianlin.ren@126.com (Qingxiang Gao)</author>
      <author>jianlin.ren@126.com (Qinyu Xu)</author>
      <author>jianlin.ren@126.com (Qiongyun Chen)</author>
      <author>jianlin.ren@126.com (Shih-Chin Cheng)</author>
      <author>jianlin.ren@126.com (Yanyun Fan)</author>
      <author>jianlin.ren@126.com (Ying Cai)</author>
      <author>jianlin.ren@126.com (Yinyin Lv)</author>
      <author>jianlin.ren@126.com (Yiqun Hu)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.107339</guid>
      <category>Immunology and Inflammation</category>
      <pubDate>Mon, 01 Jun 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-06-01T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Lipopolysaccharide stimulates dynamic changes in B cell metabolism to promote proliferation</title>
      <link>https://elifesciences.org/articles/109093</link>
      <description>Naive B cells exit quiescence and enter a proliferative state upon activation, ultimately differentiating into antibody-secreting or memory B cells. Toll-like receptor (TLR) ligands, such as lipopolysaccharide (LPS), can serve as physiological stimuli to initiate this transition. Using quantitative proteomics, we show that TLR4 engagement induces metabolic reprogramming in murine B cells, increasing the expression of amino acid transporters and cholesterol biosynthetic enzymes. The amino acid transporter SLC7A5 is markedly upregulated following LPS stimulation, and conditional deletion of &lt;i&gt;Slc7a5&lt;/i&gt; impairs B cell proliferation, underscoring its essential role in B cell activation. LPS also elevates intracellular cholesterol levels, and inhibition of the rate-limiting enzyme HMG-CoA reductase blocks proliferation. This effect was mediated by a dual requirement for cholesterol metabolism and protein prenylation downstream of HMG-CoA reductase. Notably, this was not unique to TLR4 signalling but is also observed in B cells activated via TLR7, TLR9, CD40, or the B cell receptor. Together, these findings reveal that metabolic rewiring, including amino acid uptake and cholesterol metabolism, is an essential feature of B cell activation and proliferation.</description>
      <author>j.s.c.arthur@dundee.ac.uk (Andrew JM Howden)</author>
      <author>j.s.c.arthur@dundee.ac.uk (Dana MS Cheung)</author>
      <author>j.s.c.arthur@dundee.ac.uk (Fabrizia Bonacina)</author>
      <author>j.s.c.arthur@dundee.ac.uk (J Simon C Arthur)</author>
      <author>j.s.c.arthur@dundee.ac.uk (Linda V Sinclair)</author>
      <author>j.s.c.arthur@dundee.ac.uk (Megan C Sumoreeah)</author>
      <author>j.s.c.arthur@dundee.ac.uk (Momchil Razsolkov)</author>
      <author>j.s.c.arthur@dundee.ac.uk (Stephen Andrews)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.109093</guid>
      <category>Immunology and Inflammation</category>
      <pubDate>Thu, 21 May 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-05-21T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Redirection of SARS-CoV-2 to phagocytes by intranasal sACE2-Fc as a universal decoy confers complete prophylactic protection</title>
      <link>https://elifesciences.org/articles/108883</link>
      <description>The rapid evolution of SARS-CoV-2 and other respiratory RNA viruses limits the success of current vaccines and antibody-based therapies. Engineered decoy receptors based on soluble angiotensin-converting enzyme 2 (sACE2) offer promising alternatives but show limited clinical success. This study conducted functional and mechanistic analyses using an optimized sACE2 mutant fused to human IgG1 Fc (B5-D3) as a representative, revealing redirection of virus–decoy complexes from epithelial infection to lysosomal degradation in phagocytes beyond viral neutralization. Intranasal prophylactic delivery of B5-D3 confers complete protection in SARS-CoV-2-infected K18-hACE2 mice, regardless of age. Abrogation of Fc effector functions compromises antiviral protection, indicating that Fc-mediated uptake of virus–decoy complexes is critical. Transcriptomic analysis suggests that B5-D3 induces early immune activation in the lungs of infected mice. Bio-distribution and flow cytometry reveal selective targeting of airway phagocytes. In vitro assays confirm lysosomal degradation of virus–decoy complexes by macrophages without productive infection. These findings reveal a distinct antiviral mechanism via phagocytic clearance, supporting refined regimens for decoy treatments against SARS-CoV-2 and potentially other respiratory viruses.</description>
      <author>llmpoon@hku.hk (Alex WH Chin)</author>
      <author>llmpoon@hku.hk (Bin Luo)</author>
      <author>llmpoon@hku.hk (Bo Feng)</author>
      <author>llmpoon@hku.hk (Jiale Qiu)</author>
      <author>llmpoon@hku.hk (Jiangchuan Li)</author>
      <author>llmpoon@hku.hk (Jianwei Ren)</author>
      <author>llmpoon@hku.hk (Jingyi Wang)</author>
      <author>llmpoon@hku.hk (Junkang Wei)</author>
      <author>llmpoon@hku.hk (Leo LM Poon)</author>
      <author>llmpoon@hku.hk (Thomas Braun)</author>
      <author>llmpoon@hku.hk (Yin Xia)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.108883</guid>
      <category>Immunology and Inflammation</category>
      <category>Microbiology and Infectious Disease</category>
      <pubDate>Mon, 18 May 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-05-18T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Cas9&lt;sup&gt;+&lt;/sup&gt; conditionally immortalized neutrophil progenitors as a tool for genome-wide CRISPR screening for neutrophil differentiation and function</title>
      <link>https://elifesciences.org/articles/82289</link>
      <description>Neutrophils are short-lived cells of the innate immune system that play numerous roles in defense against infection, regulation of immune responses, tissue damage and repair, autoimmunity, and other non-communicable diseases. Understanding neutrophil function at a mechanistic level has been hampered by the difficulty of working with primary neutrophils, which die rapidly upon isolation, and the relative paucity of neutrophil cell lines. Here, we report the creation of a Cas9 +ER-Hoxb8 neutrophil progenitor cell line that enables both forward and reverse genetic analysis of neutrophils. By editing progenitors via transduction with sgRNAs and then withdrawing estrogen, Cas9-edited neutrophils are produced with high efficiency. Importantly, neutrophil differentiation of edited progenitors occurs both in vitro in cell culture and when transferred into murine recipients. To demonstrate the utility of Cas9 +ER-Hoxb8 progenitors for forward genetics, we performed a pooled CRISPR screen to identify factors required for survival during neutrophil differentiation. This screen identified hundreds of genes, including &lt;i&gt;Cebpe&lt;/i&gt;, a transcription factor known to be required for neutrophil differentiation from pre-neutrophils to immature neutrophils. Using this progenitor cell line, we confirmed that &lt;i&gt;Cebpe&lt;/i&gt; is required for neutrophil differentiation in vivo, validating the utility of this line for studying in vivo phenotypes. The screen also identified all components of the WASH complex as being required for neutrophil differentiation, extending its known role in hematopoietic stem cell differentiation to later stages of neutrophil development. Taken together, this resource enables the analysis of the role of neutrophils in numerous disease states using genetics for the first time.</description>
      <author>sastanley@berkeley.edu (Alex Zilinskas)</author>
      <author>sastanley@berkeley.edu (Bianca C Hill)</author>
      <author>sastanley@berkeley.edu (Bridget A Luckie)</author>
      <author>sastanley@berkeley.edu (Gregory M Barton)</author>
      <author>sastanley@berkeley.edu (Jeffery S Cox)</author>
      <author>sastanley@berkeley.edu (Krystal L Ching)</author>
      <author>sastanley@berkeley.edu (Lillian Shallow)</author>
      <author>sastanley@berkeley.edu (Nicholas E Garelis)</author>
      <author>sastanley@berkeley.edu (Robyn M Jong)</author>
      <author>sastanley@berkeley.edu (Sagar Rawal)</author>
      <author>sastanley@berkeley.edu (Sarah A Stanley)</author>
      <author>sastanley@berkeley.edu (Xammy Huu Wrynla)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.82289</guid>
      <category>Immunology and Inflammation</category>
      <pubDate>Mon, 18 May 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-05-18T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
  </channel>
</rss>
